Yilong Ma

Has grant

Professor

Feinstein Institute for Medical Research

United States

Research Interests

Explore related searches

Professors in United States Professors in Neuroscience Neuroscience professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Yilong Ma is affiliated with the Feinstein Institutes for Medical Research in the United States. His research focuses on neurodegenerative diseases, particularly Parkinson's disease, Alzheimer's disease, and the underlying mechanisms involving genetic and metabolic factors. His recent publications include studies on the associations of genetic variants with biomarkers in plasma, as well as the application of advanced imaging techniques in clinical trials and diagnostics.

Recent Grants

Grant: Close

A Multi-Modal MRI/PET Study of Parkinsonism: Diagnosis and Disease Progression

Open Date: 2013-09-15

Close Date: 2016-07-31

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

David Eidelberg

Professor

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

UNITED STATES

View details

Wentian Li

Stony Brook University

UNITED STATES

View details

Alexander R Craven

Haukeland University Hospital

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yilong Ma

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Differential associations of APOE and TREM2 variants with glial fibrillary acidic protein and neurofilament light in plasma of UK Biobank participants support distinct disease mechanisms

Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

A disease‐specific metabolic imaging marker for diagnosis and progression evaluation of semantic variant primary progressive aphasia

Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia

Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders

Dynamic 18F-FPCIT PET: Quantification of Parkinson’s disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session

Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration

GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes

Hemispheric Network Expression in Parkinson’s Disease: Relationship to Dopaminergic Asymmetries

Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges

Brain Functional and Structural Signatures in Parkinson’s Disease

Collaborators (3)

David Eidelberg

Wentian Li

Alexander R Craven

Make your next move.